1.17
+0.0405(+3.59%)
Currency In USD
| Previous Close | 1.13 |
| Open | 1.11 |
| Day High | 1.22 |
| Day Low | 1.11 |
| 52-Week High | 2.14 |
| 52-Week Low | 0.78 |
| Volume | 134,299 |
| Average Volume | 114,566 |
| Market Cap | 19.88M |
| PE | -3.66 |
| EPS | -0.32 |
| Moving Average 50 Days | 1.11 |
| Moving Average 200 Days | 1.31 |
| Change | 0.04 |
If you invested $1000 in IRIDEX Corporation (IRIX) 10 years ago, it would be worth $165.96 as of August 18, 2025 at a share price of $1.17. Whereas If you bought $1000 worth of IRIDEX Corporation (IRIX) shares 5 years ago, it would be worth $539.17 as of August 18, 2025 at a share price of $1.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire Inc.
Jul 29, 2025 8:05 PM GMT
MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
GlobeNewswire Inc.
Jun 24, 2025 11:00 AM GMT
MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retin
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire Inc.
Apr 30, 2025 8:05 PM GMT
MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and